Código QR (código de barras bidimensional)

Long-term prognostic factors for PRRT in neuroendocrine tumors

Aim/introductionPeptide receptor radionuclide therapy (PRRT) is an effective and well-tolerated treatment option for patients with neuroendocrine tumors (NETs) that prolongs progression-free survival (PFS). However, the limited overall survival (OS) rates in the prospective phase III study (NETTER1)...

ver descrição completa

Na minha lista:
Principais autores: Nils Florian Trautwein, Johannes Schwenck, Johann Jacoby, Gerald Reischl, Francesco Fiz, Lars Zender, Helmut Dittmann, Martina Hinterleitner, Christian la Fougère
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2023-06-01
coleção:Frontiers in Medicine
Assuntos:
neuroendocrine tumor (NET)
177Lu
DOTA-TATE
peptide receptor radionuclide therapy (PRRT)
Ga-HA-DOTATATE
molecular tumor volume
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fmed.2023.1169970/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados